Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PHRthis companyPhreesia, Inc.	$12.84	347.93×	2.38×	1.67×	28.2×	269.1%	67.9%	-1.4%	0.5%	0.7%	0.3%	8.4%	0.3×	0.97×	-0.95×	1.53×	0.0%	4	1.05	3	B+
ESTAEstablishment Labs Holdings Inc.	$67.44	-42.37×	91.68×	10.23×	-105.32×	-220.3%	69.3%	-18.5%	-24.2%	-216.9%	-11.9%	-2.7%	11.23×	-8.47×	-1.54×	3.04×	0.0%	3	4.36	1	D+
GDRXGoodRx Holdings, Inc.	$3.59	31.73×	1.57×	1.21×	6.76×	43.7%	92.8%	11.0%	3.8%	4.9%	4.0%	17.0%	0.88×	1.52×	2.05×	2.61×	0.0%	7	0.27	3	B-
KMTSKestra Medical Technologies, Ltd.	$29.66	-8.53×	4.66×	12.72×	-8.45×	-619.4%	51.4%	-141.6%	-138.4%	-50.7%	-43.7%	-9.6%	0.18×	0.39×	-17.85×	4.41×	0.0%	2	5.31	1	D+
NEOGNeogen Corporation	$12.09	-223×	0.93×	2.23×	15.45×	-121.0%	46.9%	-2.5%	-0.9%	-0.4%	-0.6%	1.6%	0.38×	3.69×	-0.38×	3.82×	0.0%	6	1.45	2	C
OMCLOmnicell, Inc.	$37.58	1,015.7×	1.69×	1.76×	20.52×	-34.1%	42.9%	1.0%	0.2%	0.2%	0.1%	4.2%	0.17×	0.08×	2.98×	1.43×	0.0%	7	2.24	3	B+
Peer median	—	-8.53×	1.69×	2.23×	6.76×	-121.0%	51.4%	-2.5%	-0.9%	-0.4%	-0.6%	1.6%	0.38×	0.39×	-0.38×	3.04×	0.0%	6	2.24	2	—